ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

TRDA Entrada Therapeutics Inc

13.16
-0.40 (-2.95%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Entrada Therapeutics Inc TRDA NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.40 -2.95% 13.16 09:00:00
始値 安値 高値 終値 前日終値
13.70 12.92 13.91 13.16 13.56
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/3/1320:00GLOBEEntrada Therapeutics Reports Fourth Quarter and Full Year..
2024/3/0906:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0906:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0706:22EDGAR2Form 144 - Report of proposed sale of securities
2024/3/0706:22EDGAR2Form 144 - Report of proposed sale of securities
2024/3/0609:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0609:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0609:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0721:00GLOBEEntrada Therapeutics to Present at Upcoming Investor..
2024/1/0321:16EDGAR2Form 8-K - Current report
2024/1/0321:00GLOBEEntrada Therapeutics Promotes Nathan J. Dowden to President
2023/12/2706:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2206:26EDGAR2Form 144 - Report of proposed sale of securities
2023/12/0621:00EDGAR2Form 8-K - Current report
2023/11/2301:56DJNEntrada Therapeutics Shares Tumble 27% After FDA Keeps..
2023/11/2221:54DJNEntrada: FDA Declines to Lift Hold on Duchenne Study
2023/11/2221:35EDGAR2Form 8-K - Current report
2023/11/2221:00GLOBEEntrada Therapeutics Announces Updates on ENTR-601-44 in..
2023/11/0721:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0721:08EDGAR2Form 8-K - Current report
2023/11/0721:00GLOBEEntrada Therapeutics Reports Third Quarter 2023 Financial..
2023/11/0120:01EDGAR2Form 8-K - Current report
2023/10/1220:00GLOBEEntrada Therapeutics to Present at Upcoming Investor..
2023/9/3005:39EDGAR2Form 8-K - Current report
2023/9/3005:35EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/9/2120:09EDGAR2Form 8-K - Current report
2023/9/2120:00GLOBEEntrada Therapeutics Announces First Participant Dosed in..
2023/9/0720:00GLOBEEntrada Therapeutics Awards Funding to Non-Profit..
2023/9/0706:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/0706:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/0706:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/0706:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/0705:09EDGAR2Form 144 - Report of proposed sale of securities
2023/9/0705:09EDGAR2Form 144 - Report of proposed sale of securities
2023/9/0705:08EDGAR2Form 144 - Report of proposed sale of securities
2023/9/0605:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/0605:29EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/8/2920:00GLOBEEntrada Therapeutics to Present at Upcoming Investor..
2023/8/1020:09EDGAR2Form 8-K - Current report
2023/8/1020:00GLOBEEntrada Therapeutics Appoints Gina Chapman to its Board of..
2023/8/0820:25EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
2023/8/0820:23EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
2023/8/0820:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0820:07EDGAR2Form 8-K - Current report
2023/8/0820:00GLOBEEntrada Therapeutics Reports Second Quarter 2023 Financial..
2023/8/0505:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/0305:10EDGAR2Form 144 - Report of proposed sale of securities
2023/8/0120:08EDGAR2Form 8-K - Current report
2023/8/0120:00GLOBEEntrada Therapeutics Receives Authorization in the United..
2023/7/1305:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..

最近閲覧した銘柄

Delayed Upgrade Clock